Unchanged plasma levels of dimethylarginines and nitric oxide in chronic hepatitis C

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 2, 2009, Pages 224-228

  Lluch, Paloma ^a   Cortina, Belén ^b   Vila, José M ^b   Segarra, Gloria ^b   Mauricio, Maria D ^b   Del Olmo, Juan A ^a   Serra, Miguel A ^a   Lluch, Salvador ^b,c   Rodrigo, José M ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Chronic hepatitis C; Dimethylarginines; Interferon; Nitric oxide

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ARGININE DERIVATIVE; BILIRUBIN; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; SYMMETRIC DIMETHYLARGININE; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; ANTIVIRAL AGENTS; ARGININE; CASE-CONTROL STUDIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; NITRIC OXIDE; RIBAVIRIN;

EID: 61649096417     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520802400917     Document Type: Article

References (23)

1. Martin PY, Gines PR, Schrier W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998;339:533-41.
2. Sessa W. The nitric oxide synthase family of proteins. J Vasc Res 1994;31:131-43.
3. Clemens MG. Nitric oxide in liver injury. Hepatology 1999;30:1-5.
4. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572-5.
5. MacAllister R, Whitley G, Vallance P. Effects of guanidino and uremic compounds on nitric oxide pathway. Kidney Int 1994;45:737-42.
6. Siroen MP, van der Sijp JRM, Teerlink T, van Schaik C, Nijveldt RJ, van Leeuwen PA. The human liver clears both asymmetric and symmetric dimethylarginine. Hepatology 2005;41:559-65.
7. Lluch P, Torondel B, Medina P, Segarra G, del Olmo JA, Serra MA, et al. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. J Hepatol 2004;41:55-9.
8. Tsikas D, Rode I, Becker T, Nashan B, Klempnauer J, Frolich JC. Elevated plasma and urine levels of ADMA and 15(S)-8-iso-PGF2alpha in end-stage liver disease. Hepatology 2003;38:1063-4.
9. Nijveldt RJ, Teerlink T, van Leeuwen PA. The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr 2003;22:99-104.
10. Lluch P, Mauricio MD, Vila JM, Segarra G, Medina P, del Olmo JA, et al. Accumulation of symmetric dimethylarginine in hepatorenal syndrome. Exp Biol Med 2006;231:70-5.
11. Mookerjee RP, Malaki M, Davies NA, Hodges SJ, Dalton RN, Turner C, et al. Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis. Hepatology 2007;45:62-71.
12. Majano PL, Garcia-Monzon C. Does nitric oxide play a pathogenic role in hepatitis C virus infection? Cell Death Differ 2007;10:S13-5.
13. Amaro MJ, Bartolome J, Pardo M, Cotonat T, Lopez-Farre A, Carreño V. Decreased nitric oxide production in chronic viral hepatitis B and C. J Med Virol 1997;51:326-31.
14. Hokari A, Zeniya M, Esumi H, Ishikawa T, Kurasima Y, Toda G. Role of nitric oxide (NO) in interferon-alpha therapy for hepatitis C. J Infection 2005;51:47-53.
15. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-17.
16. Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Whitley IG, Vallance P. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 1999;343:209-14.
17. Ogawa T, Kimoto M, Sasaoka K. Purification and properties of a new enzyme, NG, NG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 1989;264:10205-9.
18. Kimoto M, Tsuji H, Ogawa T, Sasaoka K. Detection of NG, NG-dimethylarginine dimethylaminohidrolase in the nitric oxide-generating systems of rats using monoclonal antibody. Arch Biochem Biophys 1993;300:657-62.
19. Fleck C, Janz A, Scheweitzer F, Karge E, Schewertfeger M, Stein G. Serum concentration of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int 2001;suppl78:S14-8.
20. Sharara AI, Perkins DJ, Misukonis MA, Chan SU, Dominitz JA, Weinberg JB. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exper Med 1997;186:1495-502.
21. Mihm S, Fayyazi A, Ramadori G. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: relation to hepatic viral load and liver injury. Hepatology 1997;26:451-8.
22. Ersoy Y, Bayraktar NM, Mizrak B, Ozerol IH, Gunal S, Aladag M, et al. The level of endothelin-1 and nitric oxide in patients with chronic viral hepatitis B and C and correlation with histopathological grading and staging. Hepatol Res 2006;34:111-6.
23. George M, Baluch M, Van Thiel DH. Plasma and hepatic tissue levels of thrombomodulin, tissue factor, NFκB and nitric oxide in responders and nonresponders to INFα therapy. J Viral Hepatitis 2003;10:360-6.